|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7010 EUR | +2.49% |
|
-17.24% | +326.06% |
| 07-16 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 07-16 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,062B | |||||
| 619B | - | - | - | ||
| 431B | |||||
| 358B | |||||
| 293B |
Select your edition
All financial news and data tailored to specific country editions
